Clinical Trial Update: A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB [Phase 4]

View source ↗

Summary

A Phase 4 exploratory study evaluating γδ T cell-based immunotherapy for multidrug-resistant tuberculosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mdr-tb
• Tuberculosis

Drugs mentioned

• Vγ2Vδ2 T lymphocyte-based immunotherapy

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: MDR-TB, Immunotherapy | Phase 4 | Status: RECRUITING